Got News to Share? Send 2 FREE Releases ↓
All News Topics | Events By Topic | By Country | By State | By Date

Biosimilars & Biobetters USA

Submit News
Date: 07-Apr-14 to 08-Apr-14
Location: Renaissance Woodbridge Hotel, Iselin / New Jersey / United States
Category: Healthcare & Pharmaceuticals Retail Science Conferences & Trade Fairs International Organizations

After the phenomenal success of the SMi's Biosimilars and Biobetters event hosted in London in October, we are delighted to announce the launch of the Biosimilars & Biobetters Conference in Iselin, New Jersey, USA, in April 2014. Registration is now open.

Through a series of exciting panel discussions, presentations and workshops, delivered by true industry experts and players, the Biosimilars and Biobetters USA conference will offer effective strategies and solutions for developing cost effective biosimilars for the future.

Benefits of attending:
- Gain up to date insight into the regulatory landscape and how it is effecting the industry
- Evaluate commercialization and development strategies to gain a competitive advantage
- Calculate possible revenue streams from biosimilar production
- Discover what lessons have been learned so far and what the future holds
- Boost your industry knowledge and relationships by networking and learning from key industry and academic leaders

Key speakers include:
- Dr Richard Dicicco, Chairman, Harvest Moon Pharmaceuticals
- Dr John Pakulski, Senior Director, and Head US Biopharmaceutical Regulatory Affairs, Sandoz
- Rodeina Challand, Executive Director, Biosimilars Development, Scientific Affairs, PRA International
- Dr Stanley (SeungSuh) Hong, President, Research and Development, Celltrion Inc.
- Paul Ashton, President & CEO, pSivida
- Peter Pitts, President, Center for Medicine in the Public Interest (Former FDA Associate Commissioner)
- Douglas M. Long, Vice President, Industry Relations, IMS Health
- Dr Rakesh Dixit, Vice President, Research and Development Head, Global Biologics Safety Assessment, MedImmune (AstraZeneca Biologics), and many others.

Don’t miss a chance to visit 2 interactive post-conference workshops:
A. Differentiation Strategies for the Generics Industry. Workshop Leader: Asa Cox, Founder & CEO, Generic Pharma 2.0
B. Launching a Biosimilar in an Innovator v. Generic World. Workshop Leader: Kristie Kuhl, JD, Executive VP, Makovsky

Visitors

Senior Vice Presidents, Vice Presidents, Directors, Heads of Department with responsibility in the following departments:

Intellectual Property
Legislation and Policy Advisers
Analysts
Business Development
Biostatistician
Licensing
Manufacturing
Bioequivalence
Drug and Safety Assessment
Market Strategy
Regulatory/Legal Affairs
Biomedical Product Development
Health Economics
Scientific Affairs
Research and Development

Exhibitors

The SMi Group is a highly Professional, Independent and Global company that specialises in the production of Business-to-Business Conferences, Workshops and Masterclasses. We research, create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical sectors.

Go to event website

EIN News provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See: